MedPath

LEVODOPA/CARBIDOPA ENTACAPONA MYLAN 75 MG/18,75 MG/200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

LEVODOPA/CARBIDOPA ENTACAPONA MYLAN 75 MG/18,75 MG/200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Pending
Register Number

80690

Prescription Type

Medicamento Sujeto A Prescripción Médica

Authorization Date

Aug 30, 2016

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number80690
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (3)

CARBIDOPAActive
Quantity: 18,75 mg
Name: CARBIDOPA
ENTACAPONAActive
Quantity: 200 mg
Name: ENTACAPONA
LEVODOPAActive
Quantity: 75 mg
Name: LEVODOPA

ATC CLASSIFICATION (3)

N04B
N04BA
N04BA03

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.